The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Duchemin Jeffrey since year 2005.
The trader's CIK number is 1585223.
At the time of this reporting, Duchemin Jeffrey is the Chief Executive Officer of Harvard Bioscience Inc .
(stock ticker symbol HBIO).
See this page for all insider trading activities at Harvard Bioscience Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-03-08||HBIO||Harvard Bioscience Inc||Sale||79,222||4.52||358,083|
|2018-03-09||HBIO||Harvard Bioscience Inc||Sale||7,800||4.60||35,880|
|2017-06-12||HBIO||Harvard Bioscience Inc||Sale||22,000||2.66||58,520|
|2017-06-12||HBIO||Harvard Bioscience Inc||Buy||22,000||2.76||60,719|
|2016-11-03||HBIO||Harvard Bioscience Inc||Buy||15,000||2.42||36,300|
|2015-12-10||HBIO||Harvard Bioscience Inc||Buy||10,000||3.37||33,700|
|2015-09-02||HBIO||Harvard Bioscience Inc||Buy||2,000||4.41||8,820|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Duchemin Jeffrey (Chief Executive Officer of Harvard Bioscience Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.